Form 4: P3 Health Partners Director Gregory Wasson Acquires Stock Options

Director Gregory Wasson acquired stock options in P3 Health Partners Inc. on June 6, 2024, according to a Form 4 filing with the SEC.

Summary

• Gregory Wasson, a director of P3 Health Partners Inc., filed a Form 4 with the SEC.
• The filing reports a transaction on June 6, 2024, where Wasson acquired 482,640 stock options.
• These options have an exercise price of $0.5461.
• The options vest on the earlier of June 6, 2025, or the date of the next annual meeting of the Issuer's stockholders, contingent upon continued service.
• Wasson also granted power of attorney to Aric Coffman, Leslie Fisher and Atul Kavthekar to execute filings on his behalf.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock option grants, indicating a neutral sentiment.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but the vesting of the options is tied to continued service and the annual meeting.

Industry Context

This is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment as it aligns the director's interests with those of the shareholders.

Key Dates